Table 5.
Group | n | Liver; µg Fe/mg dry tissue (± SD) |
Spleen; µg Fe/mg dry tissue (± SD) |
---|---|---|---|
S0 | 3 | 1.8 (0.9) | 3.1 (2.5) |
SH | 4 | 2.1 (1.9) | 3.2 (1.3) |
LL | 3 | 17.1 (0.3) | 17.8 (14.0) |
LH | 3 | 15.7 (3.9) | 33.1 (32.3) |
H0 | 3 | 41.1 (28.0) | 36.0 (36.2) |
HL | 4 | 49.7 (29.3) | 33.2 (24.5) |
HH | 3 | 36.5 (47.9) | 72.9 (119.4) |
Iron concentrations were measured by inductively coupled plasma mass spectrometry. The first letter of each group designation indicates the dose of nanoparticles injected: saline (S), low-dose (L) or high-dose (H) superparamagnetic iron oxide. The second letter of each group designation indicates the field strength for alternating magnetic field exposure: zero (0), low (L) or high (H) field.
SD: Standard deviation.